HomeNewsBusinessIndia, US need to collaborate, operate projects jointly: Former Union Minister Suresh Prabhu

India, US need to collaborate, operate projects jointly: Former Union Minister Suresh Prabhu

Speaking at a digital conclave on 'Indo-US Trade Cooperation post-COVID-19', the former commerce and industry minister said: "Now, India and the USA need to not only continue investing in each other's countries but also invest and operate projects in other countries jointly".

April 25, 2020 / 21:14 IST
Story continues below Advertisement

There is a need for both India and the US to not only invest in each other countries but also to collaborate and operate projects jointly, former union minister Suresh Prabhu said on Saturday.

Speaking at a digital conclave on 'Indo-US Trade Cooperation post-COVID-19', the former commerce and industry minister said: "Now, India and the USA need to not only continue investing in each other's countries but also invest and operate projects in other countries jointly".

Story continues below Advertisement

The panel saw opportunities for a new realm of Indo-US trade and economic collaborations.

"The methods of wealth creation for a nation have evolved from conquering to colonization to cartels to the competition. The way forward now is collaboration. Here, India and the USA are perfect partners," said Naushad Panjwani, Regional President, Indo-American Chamber of Commerce (IACC) West India Council.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show